← Evidence map

ArticleJournal of market access & health policy2024

Comparative Efficacy of Finerenone versus Canagliflozin in Patients with Chronic Kidney Disease and Type 2 Diabetes: A Matching-Adjusted Indirect Comparison.

David Cherney et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2024
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 39193541